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Vaccinia extracellular enveloped virus (EEV) is important for cell-to-cell and long-range virus spread both in vitro and in
vivo. Six genes have been identified that encode protein constituents of the EEV outer membrane, and some of these proteins
are critical for EEV formation. The B5R gene encodes an EEV-specific type I membrane protein, and deletion of this gene
markedly decreases EEV formation and results in a small plaque phenotype. Data suggest that the transmembrane domain,
cytoplasmic tail, or both contain the EEV localization signals that are required for targeting of the B5R protein to EEV and for
EEV formation. Here, we report the construction of mutant vaccinia viruses in which the wild-type B5R gene was replaced
with a mutated one that encodes a protein with the putative cytoplasmic tail deleted. The mutated protein showed normal
intracellular distribution and was properly incorporated into EEV. Vaccinia viruses expressing the B5R protein lacking the
cytoplasmic tail formed plaques that were similar in type and size to those formed by wild-type viruses and produced
equivalent amounts of infectious EEV. These results indicate that the B5R cytoplasmic tail is not necessary for EEV formation
and points to the transmembrane domain as the major determinant for targeting the B5R protein to the outer membrane of
EEV and for supporting EEV formation. © 1998 Academic Press
INTRODUCTION
Vaccinia virus has two infectious virus forms: the in-
tracellular mature virus (IMV) and the extracellular envel-
oped virus (EEV) (Moss, 1996). The majority of progeny
virus remains within the cell as IMV, and it is speculated
that this form of virus is ultimately important in spread of
the virus from animal to animal. In contrast, EEV is critical
for the cell-to-cell and distant spread of the virus in tissue
culture and within the host (Payne, 1980) .
EEV is derived from IMV that has been enwrapped
with membranes from the trans-Golgi network containing
additional viral proteins and forms the outer envelope of
EEV (Schmelz et al., 1994; Tooze et al., 1993). These
enwrapped virions are propelled out of the cell by actin
tails in a manner similar to the movement of certain
intracellular prokaryotic organisms (Cossart, 1995; Cos-
sart and Kocks, 1994; Cudmore et al., 1995, 1996; Tilney
and Tilney, 1993). The intracellular enveloped virus also
is transported as a vesicle to the cell periphery, where it
fuses with the plasma membrane to gain access to the
extracellular compartment. In the case of vaccinia virus
strain WR, the majority of this enveloped virus remains
attached to the cell surface (Blasco and Moss, 1992). It is
believed that this virus can mediate direct spread be-
tween neighboring cells, resulting in the production of a
large, round plaque phenotype in tissue culture. In con-
trast, vaccinia virus strain IHD-J releases most of the
enveloped virus to the extracellular space as EEV, pre-
sumably generating the characteristic comet plaque
phenotype.
To date, six vaccinia virus genes have been identified
that encode proteins specifically incorporated into the
EEV outer membrane, and some of these proteins are
critical for EEV formation (Blasco and Moss, 1991; Dun-
can and Smith, 1992; Engelstad et al., 1992; Hirt et al.,
1986; Isaacs et al., 1992; Parkinson and Smith, 1994;
Payne and Norrby, 1976; Roper et al., 1996; Shida, 1986).
The B5R open reading frame (ORF) encodes one of these
EEV-specific proteins (Engelstad et al., 1992; Isaacs et
al., 1992; Takahashi-Nishimaki et al., 1991). Deletion of
the B5R gene markedly decreases EEV formation and
results in a small plaque phenotype (Engelstad and
Smith, 1993; Martinez-Pomares et al., 1993; Wolffe et al.,
1993). Based on the hydrophobicity plot and mutational
analysis, the B5R gene encodes a 317-amino-acid
polypeptide that contains an N-terminal signal peptide
(Isaacs et al., 1992), large extracellular domain, trans-
membrane region, and short cytoplasmic tail (Engelstad
et al., 1992; Isaacs et al., 1992). Recently, we and others
showed that the majority of the extracellular domain of
the B5R protein is not required for EEV formation or for
B5R protein incorporation into EEV (Herrera et al., 1998;
Mathew et al., 1998). This indicates that B5R outer-enve-
lope targeting and its ability to support EEV formation are
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likely encoded by the transmembrane or cytoplasmic
domains, or both. This is further supported by the finding
that when expressed along with the wild-type B5R pro-
tein, a chimeric protein containing only the B5R trans-
membrane and cytoplasmic domains fused to a foreign
protein extracellular portion was targeted to EEV (Katz et
al., 1997).
To address B5R structure–function relationships, we
tested the role of the predicted cytoplasmic tail in EEV
formation. The cytoplasmic tail seemed a likely candi-
date to contain the targeting signal that directs the B5R
protein to a specific cellular location that contributes to
the formation of EEV. Alternatively, the 14-amino-acid
cytoplasmic tail may aid in EEV formation by interacting
directly with viral proteins on IMV to support the enwrap-
ping of IMV with Golgi-derived membranes to form EEV.
Possibly, the cytoplasmic tail contribution to EEV forma-
tion may be because it is involved in the oligomerization
of the B5R protein and the complex formed is critical for
EEV formation. Here, we detail the investigations to de-
termine the contribution of the cytoplasmic tail domain of
the B5R protein in targeting of the B5R protein to EEV and
in EEV formation.
RESULTS
Construction of recombinant vaccinia viruses
expressing a mutated B5R protein lacking the
cytoplasmic tail
We constructed a transfer plasmid in which the wild-
type B5R gene from vaccinia virus strain WR was re-
placed with a mutated one that lacked the coding se-
quence for the final 12 amino acids of the predicted
14-amino-acid B5R protein cytoplasmic tail. To facilitate
identification of plaques that we anticipated might be
aberrant in size, a color marker was incorporated in the
transfer plasmid so that after recombination, viral
plaques could be detected by color staining. We used the
Escherichia coli b-glucuronidase gene under control of
the vaccinia virus P7.5 promoter (GUS) so the inclusion of
X-glu in the media would turn cells infected with the
mutant virus blue (Carroll and Moss, 1995) and because
X-glu is not a substrate for b-galactosidase (which is
present in the parental B5R-deletion viruses, W-B5R2
and I-B5R2).
Mutant viruses were isolated and plaque purified us-
ing reverse gpt selection (Isaacs et al., 1990) and X-glu
staining (Carroll and Moss, 1995). Proper genomic posi-
tioning of the mutated gene was confirmed by Southern
blotting (data not shown). We also verified by PCR that
the mutant viruses did not contain sequence correspond-
ing to the predicted cytoplasmic tail by using primers that
amplified a PCR product only in wild-type viruses (data
not shown).
Expression of mutated B5R protein lacking the
cytoplasmic tail
Western blots of lysates from cells infected with wild-
type virus WR or IHD-J probed with the rabbit polyclonal
anti-B5R antibody showed the expected 42-kDa band,
which was absent in the B5R-deletion viruses W-B5R2
and I-B5R2 (Fig. 1A). As described previously (Herrera et
al., 1998), the wild-type B5R protein produced by IHD-J
migrated slightly faster compared with the WR protein. A
smaller B5R protein was made by the WR-based virus
expressing the B5R protein lacking the putative cytoplas-
mic tail (W-B5RDc), consistent with the 12-residue dele-
tion. I-B5RDc produced a mutated protein of the same
size as W-B5RDc because it contained strain WR B5R
sequence lacking the cytoplasmic tail. In addition, rabbit
antibody raised against a peptide corresponding to the
cytoplasmic tail that recognized full-length B5R proteins
did not detect the mutated B5R protein produced by
W-B5RDc amd I-B5RDc, further confirming the absence
of the cytoplasmic tail (Fig. 1B). Of note, the higher-
molecular-weight bands in Fig. 1A likely represent B5R
homodimers or heterodimers (Engelstad et al., 1992;
Herrera et al., 1998; Isaacs et al., 1992) and are seen
in both the wild-type and tail-deleted B5R proteins, indi-
cating that the cytoplasmic region is not required for
oligomerization.
FIG. 1. Western blot analysis of cells infected with the panel of
vaccinia viruses. BSC-1 cells were infected with wild-type viruses (WR,
IHD-J), B5R-deletion viruses (W-B5R2, I-B5R2), or mutant viruses lack-
ing the cytoplasmic tail (W-B5RDc, I-B5RDc). At 48 h, cells were har-
vested in lysis buffer, loaded, and separated by SDS–PAGE, and pro-
teins were transferred to nitrocellulose. The blot was probed with rabbit
polyclonal antibody (C9-B5R) raised to an extracellular domain of B5R
(A). Molecular masses in kilodaltons are indicated on the left based on
color protein markers (LTI). The blot was then stripped and probed with
CT-B5R, a rabbit polyclonal antibody raised against the cytoplasmic tail
peptide (B). CT-B5R detected only the full-length ;42-kDa B5R protein.
sB5R refers to a previously described secreted form of the B5R protein
that lacks both the transmembrane and cytoplasmic domains (Isaacs et
al., 1992).
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B5RDc protein distribution in infected cells
To determine whether deletion of the predicted cyto-
plasmic tail disrupted normal targeting of the B5R protein
in infected cells, we carried out immunofluorescent
staining of infected BHK 21 cells using the anti-B5R
monoclonal antibody (Fig. 2). Cells infected with wild-
type virus (WR) showed a pattern of intense juxtanuclear
staining, suggesting a Golgi distribution, as well as a
dispersed punctate pattern that corresponds to envel-
oped virions. The B5R-deletion virus showed no staining,
whereas rescue of the B5R deletion resulted in a pattern
similar to that of the wild-type virus. In cells infected with
W-B5RDc, B5R staining showed a pattern indistinguish-
able from wild-type and B5R-rescue viruses, indicating
that the intracellular distribution of the B5R protein in the
context of a vaccinia virus infection is not determined by
the cytoplasmic tail.
Plaque phenotype of mutant viruses W-B5RDc and
I-B5RDc
We previously showed that deletion of the B5R gene
produced a small plaque phenotype (Wolffe et al., 1993),
indicating a critical role for the B5R protein in cell-to-cell
vaccinia virus spread. Here, we determined the role of
the B5R cytoplasmic tail in plaque formation (Fig. 3).
Deletion of the cytoplasmic tail of the B5R protein re-
sulted in a virus that formed plaques identical to the virus
carrying the wild-type B5R gene. This demonstrates that
the B5R protein cytoplasmic tail is not necessary for
efficient cell-to-cell spread.
EEV formation by mutant I-B5RDc
The similarity in plaque phenotypes between
W-B5RDc and I-B5RDc to their respective wild-type vi-
ruses suggested that EEV formation was not likely to be
disrupted by deletion of the cytoplasmic tail. To confirm
this, EEV formation was analyzed directly using cesium
chloride gradients of supernatants from metabolically
labeled infected RK-13 cells (Fig. 4). As expected, the
B5R-deletion virus (I-B5R2) produced minimal amounts
FIG. 2. Localization of B5R in infected cells. BHK-21 cells were
infected with wild-type virus (WR) (A), B5R-deletion virus (W-B5R2) (B),
B5R-rescued virus (W-B5Rrescue) (C), or mutant virus lacking the cyto-
plasmic tail (W-B5RDc) (D). At 7 h after infection, cells were fixed,
permeabilized, and incubated with a monoclonal anti-B5R antibody.
Secondary antibody coupled with FITC was used to visualize the
primary antibody. Representative cells are shown. Note the intense
juxtanuclear staining and dispersed punctate staining in all except
W-B5R2 (B).
FIG. 3. Plaque phenotype under liquid overlay. BSC-1 cells were infected with either WR-based viruses (A–D) or IHDJ-based viruses (E–H) and
incubated under liquid media. At 48 h, cell monolayers were stained with 0.1% crystal violet in 20% ethanol, and wells were photographed. Viruses
are WR (A), W-B5R2 (B), W-B5Rrescue (C), W-B5RDc (D), IHD-J (E), I-B5R
2 (F), I-B5Rrescue (G), and I-B5RDc (H). Note that the mutant viruses lacking the
B5R cytoplasmic tail (D and H) form plaques similar to their respective wild-type (A and E) and rescued (C and G) viruses.
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of EEV, which was restored to normal levels in the rescue
virus (I-B5Rrescue). The amount of virus at a buoyant
density corresponding to EEV found in the media of cells
infected with the cytoplasmic deletion virus (I-B5RDc)
was indistinguishable from that with the wild-type or
rescue viruses. Furthermore, titration of this virus re-
vealed that I-B5RDc had the same titer as the wild-type
and I-B5Rrescue viruses, indicating that the absence of the
cytoplasmic tail did not affect the infectivity of the mutant
virus.
We determined whether the mutant B5R protein was
incorporated into EEV at wild-type levels. This was ex-
amined by Western blotting of unlabeled EEV released
into the media of RK-13 cells (Fig. 5). This revealed that
the mutant virus lacking the B5R cytoplasmic tail
(I-B5RDc) incorporated protein at levels similar to that of
wild-type (IHD-J) or the rescued virus (I-B5Rrescue) when
compared with the amount of p37 found in EEV. As
described previously (Herrera et al., 1998), because
I-B5Rrescue was rescued with B5R sequence derived from
strain WR, the B5R protein produced by IHD-J migrates
slightly faster compared with the rescued virus.
Actin tail formation by mutant W-B5RDc
In addition to its role in EEV formation, the B5R protein
is important for the production of intracellular enveloped
forms of virus that are required for the formation of actin
tails in cells infected with vaccinia virus. The association
between intracellular enveloped virus and actin tails is
believed to play an important role in cell-to-cell spread
(Roper et al., 1998; Wolffe et al., 1997, 1998). Because the
B5R putative cytoplasmic tail might be in a position to
interact with cellular proteins involved in actin tail forma-
tion on the intracellular enveloped virus, we used phal-
loidin staining to determine whether actin tails were
formed in cells infected with our panel of viruses (Fig. 6).
As shown previously, wild-type and the rescue of the
B5R-deletion viruses formed actin tails, whereas the
B5R-deletion virus did not. Cells infected with W-B5RDc
also formed actin tails, indicating that the cytoplasmic
tail was not essential for actin tail formation.
FIG. 4. CsCl gradients of metabolically labeled virus released into the media of infected cells. RK-13 cells were infected with the B5R-deletion virus
(I-B5R2), the B5R-rescued virus (I-B5Rrescue), or the mutant virus lacking the B5R cytoplasmic domain (I-B5RDc) and incubated in the presence of
[35S]methionine and [35S]cysteine as described under Materials and Methods. After 48 h, media were centrifuged through a CsCl density gradient.
Fractions were collected from the bottom of the tube, and the radioactivity of an aliquot from each fraction was measured in a liquid scintillation
spectrometer (open symbols). The density of every other fraction was determined based on the refractive index (star symbols).
FIG. 5. Western blot of EEV-specific proteins. EEV was isolated from
the media from RK-13 cells infected with wild-type virus (IHDJ), the
rescued B5R-deletion virus (I-B5Rrescue), and the mutant virus lacking
the B5R cytoplasmic domain (I-B5RDc). Proteins were subjected to
SDS–PAGE, followed by transfer to nitrocellulose. The blot then was
probed with rabbit polyclonal antibody C9-B5R. Molecular masses in
kilodaltons are indicated on the left based on color protein markers
(LTI). sB5R refers to a previously described secreted form of the B5R
protein that serves as a positive control (Isaacs et al., 1992). The blot
was stripped and reprobed with anti-p37 antibody, and the resulting
autoradiogram is shown below the main blot.
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DISCUSSION
Defining the structure–function relationships underly-
ing vaccinia virus EEV-specific proteins is critical for
elucidating the complex process of vaccinia virus mor-
phogenesis, which remains poorly understood at the
molecular level. Furthermore, characterizing these steps
will also provide critical information regarding orthopox-
virus pathogenesis and for the development of safe and
effective recombinant poxvirus-based vaccines.
We have studied the effect of specific mutations in the
function of the B5R protein. Previously, we showed that
the deletion of the B5R gene results in viruses that are
severely impaired in IMV wrapping, EEV formation, and
actin tail induction (Herrera et al., 1998; Wolffe et al.,
1993). To define the domain or domains of the protein
responsible for these functions, here we constructed
viruses lacking most of the putative cytoplasmic tail in
the B5R protein. The cytoplasmic tail seemed a likely
candidate to contain the targeting signal that directs the
protein to a specific cellular location. Although the pre-
dicted B5R protein 14-amino-acid cytoplasmic tail
(DKNNDQYKFHKLLP) has no classic targeting motif, the
sequence of HKLLP is similar to the KKXX or KXKXX
localization signals that result in targeting to the endo-
plasmic reticulum or cis-Golgi compartments (Teasdale
and Jackson, 1996). In addition, the sequence KFHKLL
potentiality represents a di-leucine motif involved in en-
dosomal trafficking (Pond et al., 1995). We also antici-
pated that the cytoplasmic tail might have been involved
in several other aspects of B5R protein function, includ-
ing wrapping of IMV to form EEV, targeting of B5R to EEV
outer envelope, induction of actin tails, and mediating
interaction of the B5R protein with other proteins. Sur-
prisingly, however, the cytoplasmic tail is not required for
any of these functions. Because we previously showed
that the majority of the extracellular domain of the B5R
protein was dispensable for EEV formation (Herrera et
al., 1998), this indicates that the transmembrane or ex-
tracellular juxtamembrane spacer region is responsible
for these functions. Given that the transmembrane and
cytoplasmic domain of B5R can direct incorporation of a
fusion protein to the EEV envelope (Katz et al., 1997) or
target a fusion protein to the Golgi region in the absence
of infection (M. M. Lorenzo and R. Blasco, unpublished
observations), it seems likely that the transmembrane
domain plays a crucial role in both intracellular targeting
and EEV incorporation. It has yet to be determined
whether the B5R transmembrane domain, in the absence
of other B5R sequences, carries the information required
for EEV targeting and EEV formation.
Curiously, the deletion of the four putative short con-
sensus repeat (SCR) domains that compose the majority
of the extracellular domain of the B5R protein produced
a WR-derived virus that formed comet-like plaques and
did not produce actin tails (Herrera et al., 1998). The
formation of comet-like plaques is likely due to enhanced
release of cell-associated enveloped virus, suggesting a
role of the extracellular domain in tethering EEV to the
cell surface. In contrast, disruption of actin tail formation
in viruses lacking the B5R protein extracellular SCRs
remains more difficult to explain. In contrast, the B5R
cytoplasmic tail is topologically more likely to be inter-
acting with the cellular machinery required for actin
polymerization and formation of the actin tails on the
intracellular enveloped virus, yet the deletion of the cy-
toplasmic domain does not curtail actin tail formation.
Because the B5R cytoplasmic tail is highly conserved
in orthopoxviruses (Engelstad and Smith, 1993), it is
likely to possess some crucial function not yet evident,
which may be revealed by in vivo studies of these mutant
viruses. Furthermore, in addition to defining the struc-
tural determinants of B5R protein function, our data sug-
gest that the cytoplasmic tail might be used for the
delivery of antigens to EEV, which could be useful in
vaccinia virus-based vaccine development. For example,
utilization of B5R as the basis for fusion proteins would
allow efficient incorporation of immunogens into EEV,
which might be advantageous for the generation of cer-
tain immune responses (Katz and Moss, 1997). Although
incorporation of antigens as fusion proteins in place of
the extracellular domain of B5R would allow expression
on the surface of EEV (Katz et al., 1997), certain cytosolic
proteins might be more effectively incorporated as fusion
proteins attached to the inner membrane surface or
might be more effective immunogens if not exposed to
antibodies or other constituents of the extracellular en-
vironment.
FIG. 6. Actin tail formation in cells infected with vaccinia virus.
BHK-21 cells were infected with wild-type virus (WR) (A), B5R-deletion
virus (W-B5R2) (B), B5R-rescued virus (W-B5Rrescue) (C), or mutant virus
lacking the cytoplasmic tail (W-B5RDc) (D). At 7 h after infection, cells
were fixed, permeabilized, and incubated with tetramethyl rhodamine
isothiocyanate–phalloidin. Representative cells were photographed. Note
the thick actin tails in the cells infected with the mutant virus lacking
the cytoplasmic tail (W-B5RDc) (D), as well as cells infected with the
wild-type virus (WR) (A) and B5R-rescued virus (W-B5Rrescue) (C).
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MATERIALS AND METHODS
Cells
BSC-1, CV-1, and RK-13 cells were grown in MEM
(LTI/GIBCO) containing Antibiotic-Antimycotic (LTI/
GIBCO) and 10% FBS (LTI/GIBCO). STO cells were main-
tained in Dulbecco’s modified Eagle’s medium (LTI/
GIBCO) containing the identical additives. BHK-21 cells
were maintained in Glasgow MEM (GIBCO) containing
10% tryptose phosphate broth, 20 mM HEPES, 2 mM
glutamine, and 5% FBS. Vaccinia virus infections were
carried out in media containing 2.5% FBS and incubated
at 37°C in a 5% CO2 atmosphere.
Deletion of the cytoplasmic tail of the B5R protein
Deletion of the C-terminal 12 amino acids of the B5R
protein was carried out on the previously described plas-
mid pSI-80, which contains the vaccinia virus (strain WR)
B5R gene and flanking sequences (Wolffe et al., 1993).
Initially, the majority of the 39-end of the B5R ORF and the
entire right flanking sequence were removed by digest-
ing pSI-80 with BclI and HindIII. The right flanking se-
quence was regenerated by PCR using pSI-80 as a
template and primers olSI-66 (59-GGCCTGATCAGATCTC-
CGTAAATATAAATCCG-39, where the BclI site is under-
lined and a new BglII site is in italics) and olSI-65 (59-
CCCAAGCTTGCATCAACAGATAATAAC-39, where the
HindIII site is underlined). After 20 cycles of amplification
at 94°C for 2 min, 55°C for 2 min, and 72°C for 1 min
30 s, the ;620-bp PCR product was cut with BclI and
HindIII, gel purified, and ligated with the BclI/HindIII-
digested pSI-80 to produce pSIEH-115e. A mutated B5R
ORF lacking the predicted cytoplasmic tail was gener-
ated in a similar manner using PCR primers olSI-68
(59-TTTACATGTGATCAGGG-39) and olSI-67 (59-GGCC-
TGATCATTTGTCACAGGAACAAAC-39), where BclI sites
are underlined and a newly introduced in-frame stop
codon is in bold. After amplification using the identical
PCR conditions outlined above, the resulting ;780-bp
PCR fragment was digested with BclI, gel purified, and
then cloned into BclI-digested pSIEH-115e to create
pSIEH-117o. The correct orientation and proper se-
quence were confirmed by sequencing of the plasmid.
Finally, pSIEH-117o was digested with BglII to allow
introduction of the bacterial b-glucuronidase gene under
control of a vaccinia virus promoter (GUS) (Carroll and
Moss, 1995). The ;2.1-kbp GUS cassette was excised
from p7.5GUS (kindly provided by Bernie Moss and Miles
Carroll, National Institutes of Health) by cutting with SalI
and SacI. The cassette was blunted with T4 DNA poly-
merase and ligated into pSIEH-117o that had been di-
gested with BglII and blunted. The resulting plasmid,
pSIEH-118i, had the entire B5R gene, under its intrinsic
promoter, with a new stop codon at amino acid 305,
resulting in the deletion of 12 amino acids from the
predicted 14-amino-acid cytoplasmic tail, as well as a
color marker so that if small plaques were produced by
the mutant viruses, they could be identified by X-glu
staining.
Isolation of mutant viruses
The viruses W-B5R2 and I-B5R2, which represent the
deletion of the B5R gene in WR and IHD-J, respectively,
have been described previously (Wolffe et al., 1993) and
served as the parental viruses for the generation of
cytoplasmic tail mutants (B5RDc). The mutated gene was
introduced by transfection of infected cells with pSIEH-
118i using standard protocols (Earl and Moss, 1991b).
Mutant viruses were isolated using reverse gpt selection
by growth on STO cells in the presence of 6-thioguanine
as described previously (Isaacs et al., 1990) except here
we included the substrate X-glu (Clonetech Labs, Palo
Alto, CA) at a concentration of 0.2 mg/ml during the
overlay step along with neutral red (Carroll and Moss,
1995). Blue plaques were isolated and viruses under-
went three plaque purifications before expansion. The
WR-based virus expressing the B5R protein lacking the
putative cytoplasmic tail (vSIEH-29) is hereafter referred
to as W-B5RDc. The corresponding IHDJ-based virus
(vSIEH-30) containing the mutated B5R gene (strain WR)
lacking the cytoplasmic tail is referred to as I-B5RDc.
Rescue of the B5R-deletion viruses (W-B5R2 and I-B5R2)
in WR and IHD-J with the wild-type B5R gene from strain
WR, resulting in W-B5Rrescue and I-B5Rrescue, has been
described previously (Herrera et al., 1998) .
Southern blot and PCR confirmation of mutant viruses
Viral DNA was isolated from infected BSC-1 cells,
digested with SnaBI, separated on 1% agarose, trans-
ferred to Immobilon-S membrane (Millipore), and probed
using a B5R-specific probe as described previously (Earl
and Moss, 1991a; Herrera et al., 1998). We also confirmed
the deletion of the DNA corresponding to the predicted
cytoplasmic tail by PCR using a mixture of two pairs of
PCR primers. One primer pair, olSI-64 (59-GCACGGGTC-
GACCAACATGTACTGTACCCAC-39) and olSI-71 (59-GCT-
CTAGATTACGGTAGCAATTTATGG-39), creates a ;900-bp
product in wild-type viruses that retain the full cytoplas-
mic tail. The second primer pair (previously described
olSI-8 and olSI-9; Isaacs et al., 1990) was used to confirm
that viral DNA was present in the B5RDc viruses that did
not produce a product using olSI-64 and olSI-71. Prod-
ucts were amplified (30 cycles at 94°C for 2 min, 55°C for
2 min, and 72°C for 2 min) and separated on a 1.5%
agarose gel, and bands were visualized by ethidium
bromide staining.
Western blot
Western blots of infected cell lysates were carried out
using BSC-1 cells grown in 24-well plates and harvested
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48 h after infection. The cells were pelleted and lysed in
50 ml of lysis buffer as described previously (Herrera et
al., 1998). Western blots of EEV proteins were carried out
on virus released into the media by infected RK-13 cells
in T150 flasks and processed as described previously
(Herrera et al., 1998). Samples (14 ml) were boiled in
Laemmli’s loading buffer and 2-mercaptoethanol, sepa-
rated by 10% PAGE–0.1% SDS, and transferred to nitro-
cellulose. Blots were probed with rabbit polyclonal anti-
body C9-B5R at a dilution of 1:5000. C9-B5R was raised
against a peptide corresponding to a portion of the ex-
tracellular domain proximal to the transmembrane do-
main (Isaacs et al., 1992). After incubation with goat
anti-rabbit immunoglobulin G conjugated to horseradish
peroxidase (Boehringer-Mannheim) diluted to 1:10000,
bands were visualized by Renaissance Chemilumines-
cence Reagent (Dupont NEN). To confirm the presence
or absence of the putative cytoplasmic tail, blots were
stripped according to the manufacturer’s instructions
and reprobed with another polyclonal rabbit antibody,
CT-B5R, at a dilution of 1:7500. CT-B5R polyclonal anti-
body was raised to a peptide corresponding to the pre-
dicted cytoplasmic tail (Katz et al., 1997) and was the kind
gift of B. Moss (National Institutes of Health). Stripped
blots were also probed with an anti-P37 polyclonal anti-
body raised to a peptide corresponding to the predicted
N-terminus of the p37 protein (the kind gift of B. Moss)
(Katz et al., 1997). It was used at a dilution of 1:3000.
Analysis of EEV by CsCl gradient centrifugation
Virus was metabolically labeled by infecting confluent
RK-13 cells in six-well plates incubated overnight in me-
thionine- and cysteine-free media containing 100 mCi of
Tran35S-Label (ICN) as described previously (Herrera et
al., 1998) and then incubated for an additional 24 h in
complete media. The medium was removed, clarified,
and placed on a CsCl step gradient as described previ-
ously (Payne and Norrby, 1976). The gradient then was
spun in a SW-41 rotor (Beckman) at 30,000 rpm for 2 h 45
min at 15°C. Gradient fractions were collected from the
bottom of the tube, and the radioactive counts of aliquots
were measured, as well as the refractive index, as de-
scribed previously (Herrera et al., 1998).
Immunofluorescence and phalloidin staining of
infected cells
Subconfluent BHK-21 cells grown on coverslips were
infected for 2 h at a multiplicity of infection of 5 pfu/cell.
After removal of the virus inoculum, complete BHK-21
medium was added, and the cells were incubated for 7 h
at 37°C. Cells then were fixed for 10 min at room tem-
perature with cold 4% paraformaldehyde. The coverslips
were washed with PBS and permeabilized with 0.1%
Triton X-100 for 15 min at room temperature. After wash-
ing with PBS, the monolayers were treated for 5 min with
PBS–0.1 M glycine and then incubated for 30 min with
anti-B5R hybridoma supernatant, 19C2, diluted 1:100 in
PBS containing 20% FBS. Rat monoclonal antibody, 19C2
(Schmelz et al., 1994), was kindly made available by G.
Griffiths (EMBL, Germany) and used as hybridoma su-
pernatant. Cells were washed and incubated with fluo-
rescein isothiocyanate-conjugated rabbit anti-rat anti-
body (DAKO) used at a 1:50 dilution in PBS–20% FBS. For
phalloidin staining of filamentous actin structures, cells
fixed and permeabilized as above were incubated for 30
min with PBS-20% FBS containing 0.33 ng/ml tetramethyl
rhodamine isothiocyanate–phalloidin (Sigma). Finally, the
monolayers were washed extensively in PBS and
mounted with Fluorsave (Calbiochem).
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